ABI Research report: MES software for pharmaceuticals

Discover how Siemens’ Opcenter Execution Pharma leads the way in pharmaceutical, biotech and cell & gene therapy manufacturing. In a new study, ABI Research has rated Siemens as top implementer and top innovator, resulting in an overall ranking as leader in this market segment. Read the 10-page report to explore the full insights.

ABI Research: Siemens MES solution ranked Overall Leader in pharmaceuticals

The latest ABI Research Competitive Ranking places Siemens Opcenter among the top MES solutions for pharmaceutical, biotech and cell & gene therapy manufacturing. Scoring high in both innovation and implementation, Siemens Opcenter stands out for its modular, interoperable and cloud-connected capabilities, providing manufacturers with the flexibility to design and rapidly scale deployments tailored to their specific needs. Opcenter integrates advanced AI, quality management and real-time process control, making it a top choice for pharmaceutical manufacturers’ requirements.

ABI research methodology: Setting the standard for MES evaluation

ABI Research’s ranking evaluation process focuses on standout performances in innovation and implementation. Companies are scored using the Root Mean Square (RMS) method, which highlights firms that excel in key areas, such as product capabilities, accessibility, security and user experience. The ranking criteria include extensive assessments of innovation, market expertise and scalability, ensuring that only the top MES solutions are recognized as leaders. This methodology ensures that Siemens Opcenter’s high scores reflect its commitment to driving forward pharmaceutical manufacturing excellence.

Read the report and find out why Opcenter ranks as a top choice for MES solutions for pharmaceutical, biotech and cell & gene therapy manufacturing.